Retension Pharmaceuticals. Inc.
3 clinical trials · Sponsor
◉ Watch Retension Pharmaceuticals. Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension (NCT07142356) | Retension Pharmaceuticals. Inc. | 2025-10-31 |
| Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension (NCT00562549) | Retension Pharmaceuticals. Inc. | 2007-07-01 |
| Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension (NCT00562614) | Retension Pharmaceuticals. Inc. | 2007-06-01 |
Track Retension Pharmaceuticals. Inc. automatically
Every clearance here is in the API, with alerts when new ones post.